orimichaeli

orimichaeli

MRVL- forming CUP& HANDLE pattern. Target- Fib 0.5 Good luck

orimichaeli

INTEL- symmetrical move+ bear flag pointing to 16USD

orimichaeli

DLTR- massive panic selling after Trump was elected. Technically- horizonal support, RSI+ acc/dis showing buy point. Target 1- Fib 0.236 Target 2 - fib 0.382 Good luck.

orimichaeli

STM- weekly chart, Support trend line since 2016. RSI- bullish divergence. On daily chart- bullish Engulfing candle. Target- 28%

orimichaeli

SLB- Inverse H&S pattern. RSI- bullish HH&HL Target- 17.55%

orimichaeli

WBA- Huge falling wedge. Over sold for long preriot. I see double bottom on the RSI- bears starts to get exhausted. Fundamental- its worth to buy for the high dividends yields.

orimichaeli

TSLA- Expect ~30% drop after trendline rejection. Good Luck!

orimichaeli

PYPL- broke 2 bearish trendlines and hit first major resistance at 67.17+ Fib 0.236 + WEEKLY 100MA. The buy point is 70.74 and the first target is 78.32 - fib 0.382.

orimichaeli

Nike - touching a bullish trend line since 2000 + descending channel. Target -10% correction to the Previous support that is now resistance.

orimichaeli

SB1- Massive resistance, Two cypher pattern, Fib 1.272 and the RSI showing lower low indicates that the bulls are getting weaker.

orimichaeli

XABCD- should be a correction but the general direction after the correction is DOWN.

orimichaeli

CVNA- Forming cypher pattern, extremely over bought and reached to strong resistance.

orimichaeli

TSLA- perfect measured move of AB=CD and rejection from Fib 0.618.

orimichaeli

NVDA-weekly chart. 2 std deviation. You can see from the chart what happened the last 3 times NVDA touched this line.

orimichaeli

NQ1- overbought, 2 std deviation, 95% of back to mean.

orimichaeli

DIS- falling wedge, bullish cypher, divergence MACD, RSI. TP- POC

orimichaeli

GOOGL- Will go higher to close the gap and complete the pattern.

orimichaeli

PYPL- XABCD bullish pattern, Fib- 1.272. We might see correction and then double bottom or inverse H&S. Anyway, its a buy.